Astrazeneca Pharma India Ltd News
Indian pharma market grows 10.7% in August despite 3-month volume low
Pharma sales value rose to Rs 23,272 crore in August, driven by new introductions and double-digit growth in key acute and chronic therapies, even as volume growth slowed
 "Indian pharma market grows 10.7% in August despite 3-month volume low")
AstraZeneca Pharma India Q1 results: Profit drops 32% to ₹37.93 crore
AstraZeneca Pharma India Ltd on Monday reported a 32 per cent decline in profit after tax at Rs 37.93 crore in the June quarter, impacted by higher expenses. The company had posted a profit after tax of Rs 55.83 crore in the corresponding quarter last fiscal year, AstraZeneca Pharma India Ltd (AZPIL) said in a regulatory filing. Revenue from operations in the first quarter stood at Rs 682.79 crore as against Rs 526.31 crore in the corresponding period a year ago, it added. Total expenses during the quarter were higher at Rs 641.03 crore as compared to Rs 462.49 crore in the year-ago period, the company said. During the quarter, the company said it strengthened its portfolio through key regulatory approvals, expanded scientific engagement through targeted capability-building initiatives and advanced strategic partnerships that support earlier diagnosis and broader access. "The growth and momentum in the first quarter reflects the strength of our portfolio and focus on expanding acc
 "AstraZeneca Pharma India Q1 results: Profit drops 32% to ₹37.93 crore")
Stocks to Watch, June 4: Titan, NBCC, IEX, TVS Motor, NMDC, BHEL, LTM
Stocks to Watch today, June 4, 2026: From Titan to NBCC, here is a list of shares that will remain in focus
 "Stocks to Watch, June 4: Titan, NBCC, IEX, TVS Motor, NMDC, BHEL, LTM")
AstraZeneca Pharma shares slip 6% on posting 23% fall in Q4 profit YoY
In the March quarter, AstraZeneca Pharma reported a 23 per cent year-on-year (Y-o-Y) decline in consolidated net profit to ₹44.9 crore, from ₹58.25 crore a year ago